Holocene Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.8M | Sell |
469,742
-22,287
| -5% | -$2.37M | 0.12% | 169 |
|
|
2025
Q1 | $61.1M | Buy |
+492,029
| New | +$61.1M | 0.18% | 149 |
|
|
2021
Q2 | – | Sell |
-4,333
| Closed | -$712K | – | 866 |
|
|
2021
Q1 | $712K | Sell |
4,333
-667,236
| -99% | -$110M | ﹤0.01% | 718 |
|
|
2020
Q4 | $111M | Sell |
671,569
-151,833
| -18% | -$25.1M | 0.7% | 33 |
|
|
2020
Q3 | $117M | Buy |
823,402
+340,749
| +71% | +$48.6M | 0.89% | 21 |
|
|
2020
Q2 | $53.3M | Buy |
482,653
+15,404
| +3% | +$1.7M | 0.47% | 64 |
|
|
2020
Q1 | $46.6M | Buy |
467,249
+298,775
| +177% | +$29.8M | 0.5% | 57 |
|
|
2019
Q4 | $25.2M | Buy |
+168,474
| New | +$25.2M | 0.23% | 108 |
|
|
2018
Q2 | – | Sell |
-1,649
| Closed | -$249K | – | 629 |
|
|
2018
Q1 | $249K | Sell |
1,649
-3,072
| -65% | -$464K | 0.01% | 444 |
|
|
2017
Q4 | $636K | Buy |
+4,721
| New | +$636K | 0.02% | 334 |
|